International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used
Evans, M.I.; Henry, G.P.; Miller, W.A.; Bui, T.H.; Snidjers, R.J.; Wapner, R.J.; Miny, P.; Johnson, M.P.; Peakman, D.; Johnson, A.; Nicolaides, K.; Holzgreve, W.; Ebrahim, S.A.; Babu, R.; Jackson, L.
Human Reproduction 14(5): 1213-1216
ISSN/ISBN: 0268-1161 PMID: 10325263 DOI: 10.1093/humrep/14.5.1213
The development of chromosome-specific probes (CSP) and fluorescent in-situ hybridization (FISH) has allowed for very rapid identification of selected numerical abnormalities. We attempt here to determine, in principle, what percentage of abnormalities would be detectable if only CSP-FISH were performed without karyotype for prenatal diagnosis. A total of 146 128 consecutive karyotypes for prenatal diagnosis from eight centres in four countries for 5 years were compared with predicted detection if probes for chromosomes 13, 18, 21, X and Y were used, and assuming 100% detection efficiency. A total of 4163 abnormalities (2.85%) were found including 2889 (69. 4%) (trisomy 21, trisomy 18, trisomy 13, numerical sex chromosome abnormalities, and triploidies) which were considered detectable by FISH. Of these, 1274 were mosaics, translocations, deletions, inversions, rings, and markers which would not be considered detectable. CSP-FISH is a useful adjunct to karyotype for high risk situations, and may be appropriate in low risk screening, but should not be seen as a replacement for karyotype as too many structural chromosome abnormalities will be missed.